Julie E Kees

Address:

3608 Tanglewood Ct, Eagan, MN 55123

Phone:

6513730306

VIN:

2GKFLREK4C6302374

Make:

GMC

Model:

TERRAIN

Year:

2012

US Patent:

59537043, Sep 14, 1999

Filed:

Jan 15, 1997

Appl. No.:

8/784185

Inventors:

Gary Thomas McIlroy - Edina MN
Julie Ellen Kees - Eagan MN
Jacquelyn Ann Kalscheuer - Bloomington MN

Assignee:

Health Risk Management, Inc. - Minneapolis MN

International Classification:

G06F 1760

US Classification:

705 2

Abstract:

A health care management system for use by hospitals, physicians, insurance companies, health maintenance organizations, and others in the health care field includes a processing unit and health condition guidelines. A user inputs information related to the health condition of an individual and guideline treatment options are identified. The user also inputs actual or proposed and final recommendation treatments for the same individual. The resulting comparative information can be used to modify the actual or proposed treatment, or provide explanatory information as to reasons for the difference between the final recommendation treatment and guideline treatment options. Also, the comparative information can be used by a reviewer for evaluation or utilization purposes.

US Patent:

55837581, Dec 10, 1996

Filed:

Jun 7, 1995

Appl. No.:

8/475523

Inventors:

Gary T. McIlroy - Edina MN
Julie E. Kees - Eagan MN
Jacquelyn A. Kalscheuer - Bloomington MN

Assignee:

Health Risk Management, Inc. - Minneapolis MN

International Classification:

G06F 1760

US Classification:

395202

Abstract:

A health care management system for use by hospitals, physicians, insurance companies, health maintenance organizations, and others in the health care field includes a processing unit and health condition guidelines. A user inputs information related to the health condition of an individual and guideline treatment options are identified. The user also inputs actual or proposed and final recommendation treatments for the same individual. The resulting comparative information can be used to modify the actual or proposed treatment, or provide explanatory information as to reasons for the difference between the final recommendation treatment and guideline treatment options. Also, the comparative information can be used by a reviewer for evaluation or utilization purposes.